Effects of Hands-on-Healing vs. Touch for Fatigued Breast Cancer Survivors
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00440089
Recruitment Status :
First Posted : February 26, 2007
Last Update Posted : May 25, 2010
University of California, San Diego
National Center for Complementary and Integrative Health (NCCIH)
This randomized controlled trial examines the efficacy of hands-on-healing for fatigue and immune function in breast cancer survivors. Participants may be randomized to one of three groups: hands-on-healing, touch alone, or a control group.
Condition or disease
Phase 2Phase 3
Please see our website at http://healing.ucsd.edu for detailed information on the study.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 70 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Premenopausal and postmenopausal women between the ages of 18 to 70 years.
Ability to give informed consent.
Breast cancer survivors who have undergone surgery, including lumpectomy and simple or total mastectomy, followed by chemotherapy or a combination of chemo- and radio-therapy. We have elected to study survivors instead of patients actively undergoing treatment to alleviate subject burden and risk during this protocol.
Stage I to III breast cancer survivors.
Breast cancer survivors who have finished their chemotherapy and/or radiotherapy at least one month prior to 60 months prior.
Breast cancer survivors with above-normative levels of fatigue.
Breast cancer patients who are currently receiving or who are scheduled to receive radiation or chemotherapy during the course of this intervention study.
Patients with current major depression, current or history of prior bipolar illness, currently on psychotropic medications.
Patients with other diseases that are known to induce fatigue (e.g., thyroid disorder; sleep disorders).
Patients with other inflammatory diseases that affect cytokine levels.
Patients with a history of other cancers, and stage IV breast cancer.
Patients undergoing current chemotherapy and/or radiotherapy.
Men with breast cancer.
Continued use of another biofield-based intervention (e.g., Reiki, Qi-Gong, Healing Touch, Therapeutic Touch, Johrei).